Interview 136
Mantle Cell non-Hodgkin’s lymphoma was diagnosed in 1999 after she found a lump in her thigh. She was treated with chemotherapy and rituximab. She is in remission.
She found a lump in the top of her thigh, and wondered whether it might be a secondary tumour from the breast cancer she’d had three years earlier. When the lump hadn’t gone away after several weeks she decided to consult the GP. She saw a locum GP who thought it was nothing to worry about, but when pressed agreed to arrange for an ultrasound scan. The radiographer suspected an aneurism and suggested she see a vascular surgeon. The vascular surgeon said it wasn’t an aneurism but did an MRI scan that showed it to be an enlarged lymph node, and a fine needle aspiration that confirmed it was high grade non-Hodgkin’s lymphoma, so referred her to a haematologist. The lump was removed and the pathology results classified the lymphoma as Mantle Cell, which usually has a poor prognosis, although a CAT scan confirmed that it had not spread beyond the one lymph node.
The treatment plan was for CHOP chemotherapy followed by localised radiotherapy. However, after 3 chemotherapy sessions a bone marrow biopsy showed lymphoma in her bone marrow so the radiotherapy was cancelled and the chemotherapy changed to the more aggressive ESHAP. She had one dose of ESHAP followed by a dose of rituximab, and a second dose of ESHAP. They then harvested her stem cells to store for a possible future stem cell transplant if she were to relapse. Her sisters were tested to see if they could also be stem cell donors if necessary in the future, and one was found to be a perfect match. A bone marrow biopsy then showed that she was in remission.
She returned to work as a health visitor for a short while but was advised to retire on health grounds, which she did. She is now a patient representative on a professional body and a magistrate.